Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Supraz + platelet-rich plasma-fibrin glue
- Development stage
- Unknown
- Lead developer
- Mashhad University of Medical Sciences
- Modality
- Cell Therapies
- Administration
- Topical
01
Overview
Supraz + platelet-rich plasma-fibrin glue is a combination therapy being investigated for the treatment of chronic, malodorous wounds. The therapy consists of **Supraz**, a repairing gel containing approved wound-healing components designed to neutralize wound odor and promote a healthy healing environment, and **Platelet-Rich Plasma-Fibrin Glue (PRP-FG)**. PRP-FG acts as a biologic scaffold and a concentrated source of autologous growth factors, including platelet-derived growth factor (PDGF), transforming growth factor beta (TGF-β), and vascular endothelial growth factor (VEGF). These factors work synergistically to stimulate cellular proliferation, angiogenesis, and tissue regeneration. The combination is specifically designed to address the biological recalcitrance of chronic wounds while simultaneously managing the quality-of-life issues associated with wound malodor.
- Brand names
- Supraz
- Other names
- Repairing Gel + Platelet-Rich Plasma-Fibrin GlueSupraz Gel + PRP-FG
Beyond the preview
Go deeper on Supraz + platelet-rich plasma-fibrin glue.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Supraz + platelet-rich plasma-fibrin glue.